Prof. Dr. Lea Ann Dailey, Martin Luther University - Qepler Summits And Conferences

Prof. Dr. Lea Ann Dailey

Head of the Biopharmacy group
Martin Luther University
Leipzig, Germany
Martin-Luther-Universität Halle-Wittenberg

Lea Ann Dailey is a pharmacist by training and completed her PhD at the Philipps University of Marburg, Germany, on the topic of investigating the biocompatibility of polymeric nanoparticles for the controlled release of drugs in the lung.

She continued working in the field of formulation science for inhalation therapies at Nektar Therapeutics (now Novartis, San Carlos, CA, USA), followed by a position as Lecturer in Drug Delivery at King’s College London, UK, where she expanded her interests in nanotoxicology, with an emphasis on investigating the safety of nanomedicines for inhalation treatment.

In April 2016, she joined the Institute of Pharmacy at the Martin Luther University, where she continues to expand her research in the design and safety testing of inhaled products, including nanomedicines.

Related Sessions:

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 27 Feb 2019
  • Berlin, DE
  • Pharma
Day 1: Wednesday, 27 February 2019
BLOCK: FORMULATION, DEVELOPMENT & DESIGN.
CASE STUDY: Development of an in vitro high content analysis screen to assess new compounds and formulations for adverse alveolar macrophage effects.
  • Macrophage responses in non-clinical safety studies for oral inhaled products
  • Description of an in vitro high content analysis screening assay to identify and characterise compound effects on macrophages
  • Effects of different drug classes on macrophages: Beta-agonists, corticosteroids, antimuscarinics, antibiotics, etc
  • The impact of species differences on assay results
  • Future development work
View Details